Empagliflozin 25mgTablet
Diabetes & Metabolic

Empagliflozin 25mg

Empagliflozin

SGLT2 inhibitor with proven cardiovascular mortality benefit in the EMPA-REG OUTCOME trial for T2DM patients with CVD. Manufactured by Cipla and Glenmark for export.

Strengths

10mg / 25mg

Packing

10 tablets/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Empagliflozin 10mg / 25mg
Dosage Form
Tablet
Available Strengths
10mg / 25mg
Packing
10 tablets/strip
Route of Administration
Oral, with or without food
Dosage
10mg once daily in the morning; may increase to 25mg if needed
Indications
Type 2 diabetes, reduction of cardiovascular death in T2DM with CVD, heart failure with reduced ejection fraction
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C
Shelf Life
36 months
Side Effects
Genital mycotic infections, UTI, increased urination, hypotension, ketoacidosis (rare)
Precautions
Monitor for diabetic ketoacidosis; genital infection risk; volume depletion in elderly; withhold before surgery; not for type 1 diabetes; avoid if eGFR <20

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Glimepiride 2mgTablet

Glimepiride 2mg

Glimepiride

Third-generation sulfonylurea that stimulates pancreatic beta-cell insulin secretion via selective SUR1 receptor binding, offering a lower hypoglycemia risk compared to earlier sulfonylureas due to glucose-dependent activity. The most cost-effective oral antidiabetic agent in its class and a cornerstone of type 2 diabetes management in emerging markets.

1mg / 2mg / 3mg / 4mg
Sitagliptin 100mgTablet

Sitagliptin 100mg

Sitagliptin Phosphate

First-in-class DPP-4 inhibitor that amplifies incretin-mediated glucose-dependent insulin secretion while suppressing glucagon, offering glycemic control without weight gain or intrinsic hypoglycemia risk. Once-daily dosing, renal dose adjustment flexibility, and a decade-long cardiovascular safety record make it a globally preferred add-on antidiabetic.

25mg / 50mg / 100mg
Vildagliptin 50mgTablet

Vildagliptin 50mg

Vildagliptin

Selective DPP-4 inhibitor with potent enzyme inhibition that improves glycemic control through enhanced incretin-mediated insulin secretion and suppressed post-meal glucagon release. Widely prescribed as a fixed-dose combination with metformin (Galvusmet) offering convenient dual-mechanism therapy without weight gain.

50mg

Need bulk pricing for Empagliflozin 25mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote